Kohjin Bio Company Description

Kohjin Bio Co., Ltd. manufactures and sells animal blood, serum, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.

It operates through Tissue Culture Business, Microbiology Business, and Cell Processing Business segments.

The company offers tissue culture mediums for human cell culture, including human lymphocyte culture, hepatoblastoma-derived cell lines, adipose- derived stem cells, neural stem cells, fibroblast, vascular endothelial cells, and epidermal keratinocyte human cell cultures, as well as hair papilla.

It also provides industrial cell cultures for CHO, hybridomas, mammalian, and insect cells; exosome production; cryopreservation solutions; cell dispersion reagents; adoptCell-NK kits, and bags and other materials.

In addition, the company offers culture medium for clinical bacteriological testing, and food and environmental testing, drug resistance testing, and staining solutions.

Further, it offers RepliSkin 3D, a three-dimensional artificial human skin; cell culture processing contract service; culture related equipment for regenerative medicine and microorganisms; immunochromatographic assay kit; I-block series; and human blood, serum, and plasma.

Additionally, it engages in the sale of medical equipment and import and export of products and raw materials.

The company was formerly known as Kohjin Co.,Ltd and changed its name to Kohjin Bio Co., Ltd. in 1989.

Kohjin Bio Co., Ltd. was incorporated in 1981 and is headquartered in Sakado, Japan.

Kohjin Bio Co., Ltd.

Country	Japan
Founded	1981
Industry	Biotechnology
Sector	Healthcare
Employees	176
CEO	Takahito Nakamura

Contact Details

Address: 5-1-3 Sakado, 350-0214 Japan
Phone	81 49 284 3781
Website	kohjin-bio.jp

Stock Details

Ticker Symbol	177A
Exchange	Tokyo Stock Exchange
Stock Type	Common Stock
Fiscal Year	April - March
Reporting Currency	JPY
ISIN Number	JP3283630006
SIC Code	2836

Key Executives

Name	Position
Takahito Nakamura	Chief Executive Officer